$2.07 Billion Bowel Management Systems Market - Global Forecast to 2023
DUBLIN, July 26, 2018 /PRNewswire/ --
The "Bowel Management Systems Market by Product (Irrigation Systems, Nerve Modulation Devices, Colostomy Bags, and Accessories), Patient Type (Adult and Pediatric), End User (Home Care and Hospitals, Ambulatory Surgery Center) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The global bowel management systems market is projected to reach USD 2.07 billion by 2023 from USD 1.74 billion in 2018, at a CAGR of 3.5%.
Growth in the bowel management systems market is mainly driven by factors such as the expanding target patient population, the rapidly growing geriatric population, availability of technologically advanced bowel management products, and the favorable reimbursement scenario in developed countries.
This report broadly segments the bowel management systems market into product, patient type, end user, and region.
On the basis of product, the market is categorized into irrigation systems, nerve modulation devices, colostomy bags, and other products & accessories. In 2018, the colostomy bags segment is expected to account for the largest share. The large share can be attributed to the increasing number of target patient population, rising patient awareness about the clinical benefits of ostomy care, and growing availability of medical reimbursements for colostomy products across developed markets.
Based on patient type, the market is segmented into adult and pediatric patients. The adult patient segment is expected to be the fastest-growing segment of the market during the forecast period. While fecal incontinence (FI) affects individuals of all ages, it is more common in the middle age and older adults due to their greater prevalence of neurologic diseases and weaker muscle tone. The large share is primarily attributed to the significant prevalence of FI among adults across major healthcare markets, increased public-private initiatives to enhance patient awareness related to effective FI management, the growing availability of advanced bowel management products, and reimbursement in developed countries.
On the basis of end user, the bowel management systems market is segmented into home care and hospitals & ambulatory surgery centers. The home care segment is expected to dominate the bowel management systems market with a larger share in 2018. Factors such as the significant usage and growing adoption of bowel management products in home care settings, need for device replacement on a regular basis, and rising incidence of chronic disorders are expected to drive the growth of the home care segment in the coming years.
The report covers the bowel management systems market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). Europe is expected to command the largest share of the market in 2018. The strong market position of Europe in the bowel management systems market is mainly due to the significant colorectal/bladder cancer & IBD disease burden, favorable reimbursement scenario, and the increase in its geriatric population.
Key Topics Covered:
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Currency Used for the Study
1.5 Stakeholders
2 Research Methodology
2.1 Research Data
2.2 Secondary Research
2.2.1 Key Data From Secondary Sources
2.3 Primary Research
2.3.1 Key Data From Primary Sources
2.3.1.1 Breakdown of Primary Interviews
2.4 Market Size Estimation
2.4.1 Product-Based Market Estimation
2.4.2 End-User Based Market Estimation
2.4.3 Primary Research Validation
2.5 Market Breakdown and Data Triangulation
2.6 Research Assumptions
2.7 Limitations
3 Executive Summary
4 Premium Insights
4.1 Bowel Management Systems: Market Overview
4.2 Bowel Management Systems Market, By Product
4.3 Bowel Management Systems Market, By Patient Type
4.4 Bowel Management Systems Market, By End User
4.5 Geographic Snapshot of the Bowel Management Systems Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Expanding Target Patient Population
5.2.1.2 Rapidly Growing Geriatric Population
5.2.1.3 Availability of Technologically Advanced Bowel Management Products
5.2.1.4 Favorable Reimbursement Scenario in Developed Countries
5.2.2 Market Restraints
5.2.2.1 Discomfort Associated With the Use of Bowel Management Devices
5.2.2.2 Patient Preference for Non-Invasive Clinical Management of Fi
5.2.3 Market Challenges
5.2.3.1 Underreporting of Fi
5.2.3.2 Disparities in Reimbursement for Bowel Management Products in Emerging Countries
6 Bowel Management Systems Market, By Product
6.1 Introduction
6.2 Irrigation Systems
6.3 Colostomy Bags
6.4 Nerve Modulation Devices (NMD)
6.5 Other Products and Accessories
7 Bowel Management Systems Market, By Patient Type
7.1 Introduction
7.2 Adult Patients
7.3 Pediatric Patients
8 Bowel Management Systems Market, By End User
8.1 Introduction
8.2 Home Care
8.3 Hospitals & Ambulatory Surgery Centers
9 Bowel Management Systems Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Rest of the World
9.5.1 Latin America
9.5.2 Middle East and Africa
10 Competitive Landscape
10.1 Introduction
10.2 Global Bowel Management Systems Market Ranking, 2017
10.2.1 Key Players in Bowel Management Systems Market
10.3 Competitive Scenario
10.3.1 Mergers and Acquisitions (2015-2018)
10.3.2 Product Launches and Approvals (2015-2018)
10.3.3 Expansions (2015-2018)
10.3.4 Agreement (2015-2018)
10.3.5 Other Developments (2015-2018)
11 Company Profiles
11.1 Aquaflush Medical Limited
11.2 Axonics Modulation Technologies
11.3 B. Braun
11.4 C. R. Bard (Now Part of Becton Dickinson)
11.5 Cogentix Medical
11.6 Coloplast
11.7 Consure
11.8 Convatec
11.9 Hollister Incorporated
11.10 Mbh-International A/S
11.11 Mederi Therapeutics Inc.
11.12 Medtronic
11.13 Welland Medical Limited (Part of Clinimed Group)
11.14 Wellspect Healthcare (Part of Dentsply Sirona Company)
11.15 3M
For more information about this report visit https://www.researchandmarkets.com/research/vj2hf2/2_07_billion?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article